{"id":"W4391589947","doi":"10.1016/j.ygyno.2024.01.021","title":"Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"GlaxoSmithKline","keywords":"Medicine; Nausea; Quality of life (healthcare); Placebo; Constipation; Internal medicine; Vomiting; Ovarian cancer; Cancer; Randomized controlled trial; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00194634,0.0008822002,0.002310445,0.0002286538,0.0002294292,0.0008151928,0.0005459852,0.0009245578,0.002755056],"category_scores_gemma":[0.001388604,0.0003187292,0.001766313,0.0003035323,0.0005813806,0.0006271151,0.0003276536,0.00198133,0.0003434059],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00041056,"about_ca_system_score_gemma":0.0005439003,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002858216,"about_ca_topic_score_gemma":0.0007949512,"domain_scores_codex":[0.9993464,0.0004241536,0.00004393763,0.00008706449,0.00004674007,0.00005166002],"domain_scores_gemma":[0.999316,0.0002078562,0.0002289582,0.00005018027,0.00003154856,0.0001654655],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9614403,0.004051008,0.00209551,0.0006651986,0.001113663,0.00003883218,0.00003888253,0.0002790352,0.002185073,0.00003927189,0.0005390776,0.02751407],"study_design_scores_gemma":[0.8772746,0.1089925,0.01094814,0.00007624764,0.0008344154,0.00008978146,0.00002964035,0.0004525082,0.0004269574,0.0001406742,0.0007196703,0.00001487692],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9865749,0.010001,0.0002157721,0.0004157721,0.0002515621,0.000909389,0.0005829124,0.00003908502,0.001009577],"genre_scores_gemma":[0.9932586,0.00306352,0.0004288129,0.0005729981,0.0002571098,0.001045586,0.0007210376,0.000009693408,0.0006426608],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002755056,"threshold_uncertainty_score":0.01029336,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03742922405848668,"score_gpt":0.3674416813460257,"score_spread":0.330012457287539,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}